Stratos Genomics Adds Roche Vet

Share

Stratos Genomics, the Seattle-based developer of low-cost gene sequencing technology, said today it has has added Heiner Dreismann, the former CEO of Roche Molecular Diagnostics, to its board of directors. Dreismann, 57, is known for pushing for wide adoption of polymerase chain reaction technology as a basic research tool in the 1990s. Dreismann said in a statement that Stratos Genomics “has the potential to radically transform the molecular diagnostics industry.”